Codexis, Inc. - Common Stock — Cash Flow (NASDAQ:CDXS) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Documents

Quarterly Annual

Cash from operating activities -16.46 M-14.27 M11.28 M-52.64 M-49.41 M-19.38 M -10.4 M Cash from investing activities -5.75 M-21.42 M-13.58 M-4.86 M-56.98 M23.5 M 11.16 M Cash from financing activities 80.81 M3.77 M-575 K8.17 M60.52 M27.93 M 121 K Free cash flow -16.46 M-14.27 M11.28 M-52.64 M-49.41 M-23.85 M -12.18 M

News

Codexis (CDXS) Upgraded to Buy: What Does It Mean for the Stock?

Codexis (CDXS) Reports Q2 Loss, Tops Revenue Estimates

ANI Pharmaceuticals (ANIP) Q2 Earnings and Revenues Beat Estimates

Arcturus Therapeutics (ARCT) Reports Q2 Loss, Beats Revenue Estimates

AC Immune (ACIU) Beats Q2 Earnings and Revenue Estimates

Codexis: ECO Synthesis And Runway Reset Warrant An Upgrade (NASDAQ:CDXS)

Codexis, Inc. (CDXS) Q1 2026 Earnings Call Transcript

Codexis (CDXS) Reports Q1 Loss, Beats Revenue Estimates

Fortrea Holdings Inc. (FTRE) Beats Q1 Earnings Estimates

Codexis (CDXS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Codexis Posts Strong Q4, Eyes siRNA Market With ECO Synthesis Platform (NASDAQ:CDXS)

Cantor Fitzgerald reiterates Codexis stock rating on siRNA deal